- Article
Predictive Markers of Treatment Response to Neoadjuvant Systemic Therapy with Dual HER2-Blockade
- Soong June Bae,
- Jee Hung Kim,
- Min Ji Lee,
- Seung Ho Baek,
- Yoonwon Kook,
- Sung Gwe Ahn,
- Yoon Jin Cha and
- Joon Jeong
In patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer, achievement of pathologic complete response (pCR) is a known prognostic indicator after neoadjuvant systemic therapy (NAST). We investigated the clinicopathologi...

